Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)
Almansa de Cara, S.
Revista Clinica Espanola 125(4): 353-356
1972
ISSN/ISBN: 0014-2565 PMID: 5080180 Document Number: 51490
Document emailed within 1 workday
Related Documents
Anagonou, S.Y.; Gninafon, M.; Josse, R.; Kinde-Gazard, D.; Tawo, L.; Foundohou, J. 1993: Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin) Bulletin de la Societe de Pathologie Exotique 86(2): 144-147Thakur, C.P.; Sinha, P.K. 1989: Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar Journal of Tropical Medicine and Hygiene 92(6): 383-385
Van Scoy, R.E.; Wilkowske, C.J. 1983: Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide Mayo Clinic Proceedings 58(4): 233-240
Skakun, N.P.; Tabachuk, O.E. 1991: Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol Problemy Tuberkuleza 1991(10): 77-79
Arkuszewska, C. 1980: Direct evaluation of the results of treatment of cutaneous tuberculosis with streptomycin, isoniazid and ethambutol Przeglad Dermatologiczny 67(1): 97-101
Engbaek, H.C.; Larsen, S.O.; Rasmussen, K.N.; Vergmann, B. 1973: Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin Scandinavian Journal of Respiratory Diseases 54(2): 83-91
Hinaut, G.; Bosio, A.M.; Estampes, B. 1970: Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide Revue de Tuberculose et de Pneumologie 34(2): 291-295
Richard, C.; Quevauvilliers, J. 1983: Acute adrenal insufficiency induced by antitubercular treatment in an addisonian woman. Possible role of the rifampicin-isoniazid combination Presse Medicale 12(12): 767-768
Zeliger, L.R.; Kivman, G.I.; Makarova, R.A.; Chaĭkovskaia, S.M. 1982: Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid Antibiotiki 27(3): 173-176
Janowiec, M.; Zwolska-Kwiek, Z.; Wiśniewska, A.; Wróblewska, H. 1977: Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli Pneumonologia Polska 45(6): 425-430
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Favez, G. 1970: A new antitubercular agent: rifampicin Schweizerische Rundschau für Medizin Praxis 59(8): 296-297
Zyczyński, T. 1972: Rifampicin: a new antitubercular agent Wiadomosci Lekarskie 25(3): 251-254
Ginzburg, T.S.; Drabkina, R.O. 1972: Antitubercular activity and pharmacokinetics of rifampicin Antibiotiki 17(7): 607-611
Araszkiewicz, A.; Miravet, L.; Cohen-Solal, L.; Hioco, D. 1973: Effects of rifampicin and ethambutol on calcium metabolism in the rat Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(6): 875-881
Sato, Y.; Ono, H.; Amada, K.; Nakahara, R.; Itoh, H. 2017: Comparison of Preparation Efficiency and Therapeutic Safety between Generic Products of Gemcitabine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(4): 319-323
Gontsa, F.T.; Savina, L.A.; Tsurkan, V.P.; Kovalenko, I.P. 1988: Phenotype of isoniazid acetylation and tolerance of antitubercular drugs Problemy Tuberkuleza 2: 35-38
Bialik, I.B.; Klimenko, M.T. 1973: Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro Problemy Tuberkuleza 51(2): 56-61
Kozma, D.; Mihalik, P. 1984: Liver and kidney damage in rifampicin and ethambutol treatment Zeitschrift für Erkrankungen der Atmungsorgane 162(3): 249-255